ArticleJournal of molecular neuroscience : MN2025
Investigating Oxidative Stress and Impaired DNA Repair Capacity as Diagnostic Biomarkers in Autism Spectrum Disorder.
Article in Journal of molecular neuroscience : MN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Disruption of DNA Repair as an Emerging Epigenetic Mechanism Underlying Autism Spectrum Disorder.Current psychiatry reports · 2026Review
- Autism Spectrum Disorder: What Do We Know and Where Do We Go?Brain sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by early-onset social communication deficits, restricted/repetitive behaviors, and sensory sensitivities. Although ASD is predominantly influenced by genetic factors, accumulating evidence implicates oxidative stress as a contributing mechanism in its pathophysiology. This study included a total of 89 children, of whom 60 were diagnosed with ASD and 29 were healthy controls. The severity of autism was assessed according to the criteria established in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The study measured the levels of 8-hydroxydeoxyguanosine (8-OHdG), 8-oxoguanine DNA glycosylase 1 (OGG1), 3-nitrotyrosine (3-NT), and advanced oxidation protein products (AOPP) using the sandwich ELISA method. The results demonstrate a significant elevation of 8-OHdG in the ASD group compared to the control group (p = 0.043), which positively correlated with ASD symptom severity (p = 0.029). Conversely, OGG1 levels were significantly reduced in ASD (p = 0.0004) and were strongly linked to more severe ASD symptoms (p = 0.0001). Moreover, both 3-NT (p = 0.0005) and AOPP (p = 0.043) levels were significantly elevated in ASD and showed positive correlations with ASD severity (p = 0.0043 and p = 0.046, respectively). The present findings demonstrate marked elevation in oxidative DNA damage, evidenced by increased levels of 8-OHdG and decreased concentrations of OGG1, as well as enhanced protein oxidation, reflected by heightened 3-NT and AOPP levels, in children diagnosed with ASD. The strong correlations observed between elevated oxidative stress biomarkers, diminished OGG1 levels, and increased ASD severity underscore their utility as potential indicators of disease severity and provide key mechanistic insights into ASD pathophysiology.
Indexed as
Identifiers
40719985What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.